Culture-proven Infection Clinical Trial
Official title:
Clinical Presentations, Microbiology, Antibiotic Resistance Patterns and Management Outcomes of Culture-proven Infection Among Adolescent and Adult in A Tertiary Hospital in Saudi Arabia
| NCT number | NCT04395586 |
| Other study ID # | ACH-1 |
| Secondary ID | |
| Status | Withdrawn |
| Phase | |
| First received | |
| Last updated | |
| Start date | July 1, 2020 |
| Est. completion date | June 30, 2021 |
| Verified date | December 2021 |
| Source | Aseer Central Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The characteristics of patients as well as microbiologic profile of culture-proven infection will be studies in conjunction with clinical outcome within 28-days
| Status | Withdrawn |
| Enrollment | 0 |
| Est. completion date | June 30, 2021 |
| Est. primary completion date | June 30, 2021 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 13 Years and older |
| Eligibility | Inclusion Criteria: - Any individual aged =13 year old requested for him/her bacterial/fungal culture. - Able to provide a written informed consent. Exclusion Criteria: - Age <13 years old. - Unable/unwilling to provide a written informed consent. |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Aseer Central Hospital |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Mortality | All-cause and disease specific mortality | 28 days |